ALB and venous thromboembolism: Low serum albumin, whose synthesis is stimulated by BCAA supplementation [20,21,22,23,24], has been associated with venous thromboembolism [35,36], major adverse cardiovascular events [35,36,37,38], and cardiovascular death [39,84].